HENLIUS (02696): The Hong Kong Stock Exchange approves the listing of the company's H shares for full circulation.
Fosun Pharma (02696) announced that the company has received approval from the Hong Kong Stock Exchange dated January 19, 2026 for the listing and trading of 182,645,856 H shares (the total number of non-listed shares that are to be converted and listed). The conversion and listing will involve a total of 17 shareholders holding 182,645,856 non-listed shares, with the number of converted H shares held by these participating shareholders accounting for approximately 33.61% of the total number of issued shares of the company as of the date of this announcement.
HENLIUS (02696) announced that the company has received approval from the Stock Exchange for the listing and trading of 182,645,856 H shares (the total number of non-listed shares to be converted and listed) with an effective date of January 19, 2026. The conversion and listing will involve a total of 17 participating shareholders who collectively hold 182,645,856 non-listed shares, with the number of H shares to be converted held by these participating shareholders representing approximately 33.61% of the total issued share capital of the company as of the date of this announcement.
Related Articles
Change in controlling ownership: ETS GROUP (08031) receives a cash takeover offer at a discount of approximately 15.08%, and will resume trading on January 20th.
MODERN CHI MED (01643) plans to acquire a 30% stake in Shuzhi Health Global for 41.82 million Hong Kong dollars.
CMON is planning to offer a discount of approximately 16.67% in the maximum of 10.32 million shares, netting approximately 7.9 million Hong Kong dollars.
Change in controlling ownership: ETS GROUP (08031) receives a cash takeover offer at a discount of approximately 15.08%, and will resume trading on January 20th.
MODERN CHI MED (01643) plans to acquire a 30% stake in Shuzhi Health Global for 41.82 million Hong Kong dollars.
CMON is planning to offer a discount of approximately 16.67% in the maximum of 10.32 million shares, netting approximately 7.9 million Hong Kong dollars.
